Patents by Inventor Mark Carty

Mark Carty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250292114
    Abstract: Systems and methods for distributing diagnostic prediction models. The system may receive, from an application provider, one or more diagnostic prediction models, each model trained to generate a respective diagnostic prediction based upon genomic data. Adaptation factors may be used to transform a target genomic dataset to conform to a dataset-specific nature of a reference genomic dataset of the model. The system may display via a graphical user interface, one or more representations corresponding to the diagnostic prediction models, and verify a diagnostic prediction model for an application consumer based upon receiving information corresponding to an application consumer genomic dataset. The system may authorize the diagnostic prediction model for distribution to the application consumer, and provide the diagnostic prediction model and the corresponding adaptation factors to the application consumer.
    Type: Application
    Filed: March 15, 2024
    Publication date: September 18, 2025
    Inventors: Raphael Pelossof, Talal Ahmed, Mark Carty, Kaveri Nadhamuni
  • Publication number: 20250157586
    Abstract: A computer-implemented method, computing system and computer-readable medium for determining HER2-low status of a patient using molecular data of the patient includes: (a) receiving digital biological data; (b) processing the digital biological data using a trained multi-stage machine learning architecture; (c) generating a digital HER2-low status report corresponding to the patient; and (d) causing the digital HER2-low status report to be displayed. A computer-implemented method, computing system and computer-readable medium for training a model architecture to determine HER2-low status of a patient using molecular data of the patient includes: (a) receiving training digital biological data; (b) initializing a machine learning model; (c) processing the plurality of molecular signatures using the machine learning model to generate a trained machine learning model; and (d) storing the trained machine learning.
    Type: Application
    Filed: November 15, 2024
    Publication date: May 15, 2025
    Inventors: Talal Ahmed, Raphael Pelossof, Mark Carty, Kaveri Nadhamuni
  • Publication number: 20250157665
    Abstract: A implemented method, computing system and computer-readable medium for stratifying patient cancer risk using molecular data includes receiving molecular data; processing the molecular data using a machine learning model; and generating a matched treatment strategy for the patient based upon the patient's molecular data risk. A computer-implemented method, computing system and computer-readable medium for training a machine learning model to stratify patient cancer risk using molecular data includes receiving a patient training dataset, and a reference training dataset; selecting a cohort of patients; selecting a small subset of genes using univariate selection; generating a corrected reference training dataset; selecting a smaller subset of genes using multivariate selection; training a survival model; and (g) selecting a decision threshold to identify a patient population.
    Type: Application
    Filed: November 15, 2024
    Publication date: May 15, 2025
    Inventors: Talal Ahmed, Raphael Pelossof, Mark Carty
  • Publication number: 20240355485
    Abstract: The disclosure provides methods and systems for predicting an effect of a pharmaceutical agent in a test subject of a first species. Information about the test subject is input into a multi-task model comprising a plurality of parameters. The model applies the plurality of parameters to the information about the test subject through a plurality of instructions to generate, as output from the multi-task model, a plurality of outputs including a predicted effect of the pharmaceutical agent in the test subject and, for each respective cell type variable in a set of one or more cell type variables, a corresponding cell type classification. The information about the test subject includes a plurality of abundance values including, for each respective cellular constituent in a plurality of cellular constituents, a corresponding abundance value for the abundance of the respective cellular constituent in a biological sample of the test subject.
    Type: Application
    Filed: April 15, 2024
    Publication date: October 24, 2024
    Inventors: Mark Carty, Raphael Pelossof, Talal Ahmed, Ameen Salahudeen
  • Publication number: 20220101952
    Abstract: A method for transferring a dataset-specific nature of a first dataset with sequencing results for a first plurality of specimen to a second dataset with sequencing results for a second plurality of specimen includes receiving a first set of adaptation factors of the first dataset that include two or more eigenvectors, where the sequencing cannot be reconstructed from the first set of adaptation factors without access to the first dataset. The method also includes generating a second set of adaptation factors of the second dataset that include two or more eigenvectors of the second dataset. The method also includes generating an adapted second dataset by adapting the dataset-specific nature of the second dataset to the dataset-specific nature of the second dataset based at least in part on the first and second sets of adaptation factors, and providing the adapted second dataset to the first entity.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Inventors: Talal Ahmed, Raphael Pelossof, Stephane Wenric, Mark Carty
  • Publication number: 20220101951
    Abstract: A method for transferring a dataset-specific nature of a first dataset with sequencing results for a first plurality of specimen to a second dataset with sequencing results for a second plurality of specimen includes receiving a first set of adaptation factors of the first dataset that include two or more eigenvectors, where the sequencing cannot be reconstructed from the first set of adaptation factors without access to the first dataset. The method also includes generating a second set of adaptation factors of the second dataset that include two or more eigenvectors of the second dataset. The method also includes generating an adapted second dataset by adapting the dataset-specific nature of the second dataset to the dataset-specific nature of the second dataset based at least in part on the first and second sets of adaptation factors, and providing the adapted second dataset to the first entity.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Inventors: Talal Ahmed, Raphael Pelossof, Stephane Wenric, Mark Carty
  • Publication number: 20220059190
    Abstract: A method for transferring a dataset-specific nature of a first dataset with sequencing results for a first plurality of specimen to a second dataset with sequencing results for a second plurality of specimen includes receiving a first set of adaptation factors of the first dataset that include two or more eigenvectors, where the sequencing cannot be reconstructed from the first set of adaptation factors without access to the first dataset. The method also includes generating a second set of adaptation factors of the second dataset that include two or more eigenvectors of the second dataset. The method also includes generating an adapted second dataset by adapting the dataset-specific nature of the second dataset to the dataset-specific nature of the second dataset based at least in part on the first and second sets of adaptation factors, and providing the adapted second dataset to the first entity.
    Type: Application
    Filed: August 18, 2021
    Publication date: February 24, 2022
    Inventors: Talal Ahmed, Raphael Pelossof, Stephane Wenric, Mark Carty